Systemic Diseases with Oral Manifestations and Their Impact on Health-Related Quality of Life

Vujovic, Sanja; Desnica, Jana; Stanisic, Dragana; Ognjanovic, Irena; Milenkovic, Jovana; Stevanovic, Momir; Rosic, Gvozden; Jovicic, Nemanja; Milovanovic, Dragan

doi:10.2478/sjecr-2021-0074

References

1. Haag DG, Peres KG, Balasubramanian M, Brennan DS. Oral Conditions and Health-Related Quality of Life: A Systematic Review. J Dent Res 2017;96(8):864-74.10.1177/002203451770973728581891
Search in Google Scholar Back to article
2. Tackmann E, Dettmer S. Health-related quality of life in adult heart-transplant recipients-a systematic review. Herz 2020;45(5):475-82.10.1007/s00059-018-4745-830191263
Search in Google Scholar Back to article
3. Gift HC, Atchison KA. Oral health, health, and healthrelated quality of life. Med Care 1995;33(11): NS57– NS77.10.1097/00005650-199511001-000087475433
Search in Google Scholar Back to article
4. Yeoh, S.C., Hua, H., Yepes, J.F., Peterson, D.E. (2018). Contemporary Oral Medicine. New York, USA: Springer, Cham.
Search in Google Scholar Back to article
5. Gaddey HL. Oral manifestations of systemic disease. Gen Dent 2017;65(6):23-9.
Search in Google Scholar Back to article
6. Mulliken RA, Casner MJ. Oral manifestations of systemic disease. Emerg Med Clin N Am 2000;18(3):565-75.10.1016/S0733-8627(05)70144-9
Search in Google Scholar Back to article
7. World Health Organization (WHO). Study protocol for the World Health Organization project to develop a Quality of Life assessment instrument (WHOQOL). Qual Life Res 1993;2(2):153-9.10.1007/BF00435734
Search in Google Scholar Back to article
8. Kolotkin RL, Andersen JR. A systematic review of reviews: exploring the relationship between obesity, weight loss and health-related quality of life. Clin Obes 2017;7(5):273-89.10.1111/cob.12203560009428695722
Search in Google Scholar Back to article
9. Paterson C. Quality of life measures. Br J Gen Pract 2010;60(570):53.10.3399/bjgp10X482121280178620040170
Search in Google Scholar Back to article
10. Čanković S, Nikolić E, Čanković D, Radić I, Harhaji S. Quality of Life - Theoretical Approach. J Health Care 2011;40(5):1-6.10.5937/ZZ1105001C
Search in Google Scholar Back to article
11. Baiju RM, Peter E, Varghese NO, Sivaram R. Oral Health and Quality of Life: Current Concepts. J Clin Diagnost Res 2017;11(6):21-6.10.7860/JCDR/2017/25866.10110553549828764312
Search in Google Scholar Back to article
12. Strömbeck B, Ekdahl C, Manthorpe R, Wikström I, Jacobsson L. Health-related quality of life in primary Sjögren’s syndrome, rheumatoid arthritis and fibromyalgia compared to normal population data using SF-36. Scand J Rheumatol 2000;29(1):20-8.10.1080/03009740075000176110722254
Search in Google Scholar Back to article
13. Devlin NJ, Brooks R. EQ-5D and the EuroQol Group: Past, Present and Future. Appl Health Econ Health Policy 2017;15(2):127-37.10.1007/s40258-017-0310-5534308028194657
Search in Google Scholar Back to article
14. Gelber, R. (1995). Measuring disease: a review of disease- specific quality of life measurement scales. Philadelphia, USA: Open University Press.
Search in Google Scholar Back to article
15. Huang CI, Lee JL, Ketheeswaran P, Jones CM, Revicki DA, Wu AW. Does personality affect health-related quality of life? A systematic review. PLoS One 2017;12(3):e0173806.10.1371/journal.pone.0173806537132928355244
Search in Google Scholar Back to article
16. Haraldstad K, Wahl A, Andenæs R, et al. A systematic review of quality of life research in medicine and health sciences. Qual Life Res 2019;28(10):2641-50.10.1007/s11136-019-02214-9676125531187410
Search in Google Scholar Back to article
17. Bansback N, Harrison M, Brazier J, et al. Health state utility values: a description of their development and application for rheumatic diseases. Arthritis Rheum 200815;59(7):1018-26.10.1002/art.2381318576311
Search in Google Scholar Back to article
18. Meregaglia M, Nicod E, Drummond M. The estimation of health state utility values in rare diseases: overview of existing techniques. Int J Technol Assess Health Care 2020;36(5):469-73.10.1017/S026646232000066532981547
Search in Google Scholar Back to article
19. Centers for Disease Control and Prevention. Measuring healthy days: Population assessment of health-related quality of life. Centers for Disease Control and Prevention, Atlanta, Georgia, 2000.
Search in Google Scholar Back to article
20. Fuente Hernández, J., Carmen Aguilar Díaz, F. & Carmen Villanueva Vilchis, M. (2015). Emerging Trends in Oral Health Sciences and Dentistry (1st ed.). Rijeka, Croatia:InTech.
Search in Google Scholar Back to article
21. Bagramian, R.A. (2002). Oral Health Related Quality of Life. Illinois, USA: Quintessence Publishing Co. Inc.
Search in Google Scholar Back to article
22. Schmalz G, Patschan D, Schmickler J, et al. Oral healthrelated quality of life in different rheumatic diseases. Oral Dis 2020;26(8):1783-92.10.1111/odi.1346432510714
Search in Google Scholar Back to article
23. Gift HC, Atchison KA, Dayton CM. Conceptualizing oral health and oral health related quality of health. Soc Sci Med 1997;44(5):601-8.10.1016/S0277-9536(96)00211-09032828
Search in Google Scholar Back to article
24. Slade, G.D. (2002). Oral Health-Related Quality of Life. Illinois, USA: Quintessence Publishing Co. Inc.
Search in Google Scholar Back to article
25. Stancić I, Sojić LT, Jelenković A. Adaptation of Oral Health Impact Profile (OHIP-14) index for measuring impact of oral health on quality of life in elderly to Serbian language. Vojnosanit Pregl 2009;66(7):511-5.10.2298/VSP0907511S19678573
Search in Google Scholar Back to article
26. Bennadi D, Reddy CV. Oral health related quality of life. J Int Soc Prev Community Dent 2013;3(1):1-6.10.4103/2231-0762.115700389409824478972
Search in Google Scholar Back to article
27. McGrath C, Broder H, Wilson-Genderson M. Assessing the impact of oral health on the life quality of children: Implications for research and practice. Community Dent Oral Epidemiol 2004;32:81-5.10.1111/j.1600-0528.2004.00149.x15061856
Search in Google Scholar Back to article
28. Casamassimo PS, Flaitz CM, Hammersmith K, Sangvai S, Kumar A. Recognizing the Relationship Between Disorders in the Oral Cavity and Systemic Disease. Pediatr Clin N Am 2018;65(5):1007-32.10.1016/j.pcl.2018.05.00930213346
Search in Google Scholar Back to article
29. Saccucci M, Di Carlo G, Bossù M, Giovarruscio F, Salucci A, Polimeni A. Autoimmune Diseases and Their Manifestations on Oral Cavity: Diagnosis and Clinical Management. J Immunol Res 2018;1-6.10.1155/2018/6061825599427429977929
Search in Google Scholar Back to article
30. Meijer JM, Meiners PM, Huddleston Slater JJR, et al. Health-related quality of life, employment and disability in patients with Sjögren’s syndrome. Rheumatology 2009; 48(9):1077-82.10.1093/rheumatology/kep14119553376
Search in Google Scholar Back to article
31. Bayetto K, Logan RM. Sjögren’s syndrome: a review of aetiology, pathogenesis, diagnosis and management. Aust Dent J 2010;55:39-47.10.1111/j.1834-7819.2010.01197.x20553243
Search in Google Scholar Back to article
32. Bolstad AI, Skarstein K. Epidemiology of Sjögren’s syndrome – from an oral perspective. Curr Oral Health Rep 2016;3:328-36.10.1007/s40496-016-0112-0510479227891302
Search in Google Scholar Back to article
33. Cartee DL, Maker S, Dalonges D, Manski MC. Sjögren’s Syndrome: Oral Manifestations and Treatment, a Dental Perspective. J Dent Hyg 2015;89(6):365-71.
Search in Google Scholar Back to article
34. Serrano J, López-Pintor RM, Fernández-Castro M, et al. Oral lesions in patients with primary Sjögren’s syndrome. A case-control cross-sectional study. Med Oral Patol Oral Cir Bucal 2020;25(1):137-43.10.4317/medoral.23254698299231880282
Search in Google Scholar Back to article
35. Błochowiak K, Olewicz-Gawlik A, Polańska A, et al. Oral mucosal manifestations in primary and secondary Sjögren syndrome and dry mouth syndrome. Postepy Dermatol Alergol 2016;33(1):23-7.10.5114/pdia.2016.57764479306026985175
Search in Google Scholar Back to article
36. Fernández-Martínez G, Zamora-Legoff V, Hernández Molina G. Oral health-related quality of life in primary Sjögren’s syndrome. Reumatol Clin 2020;16(2 Pt 1):92-6.10.1016/j.reumae.2018.04.001
Search in Google Scholar Back to article
37. Seror R, Ravaud P, Bowman SJ, et al. EULAR Sjogren’s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren’s syndrome. Ann Rheum Dis 2010;69(6):1103-9.10.1136/ard.2009.110619293702219561361
Search in Google Scholar Back to article
38. Seror R, Bowman SJ, Brito-Zeron P, et al. EULAR Sjögren’s syndrome disease activity index (ESSDAI): a user guide. RMD Open 2015;1(1):e000022.10.1136/rmdopen-2014-000022461315926509054
Search in Google Scholar Back to article
39. Meiners PM, Arends S, Brouwer E, Spijkervet FK. Responsiveness of disease activity indices ESSPRI and ESSDAI in patients with primary Sjogren’s syndrome treated with rituximab. Ann Rheum Dis 2012;71(8):1297-302.10.1136/annrheumdis-2011-20046022258489
Search in Google Scholar Back to article
40. Lackner A, Stradner MH, Hermann J, et al. Assessing health-related quality of life in primary Sjögren’s syndrome- The PSS-QoL. Semin Arthritis Rheum 2018;48(1):105-10.10.1016/j.semarthrit.2017.11.00729395257
Search in Google Scholar Back to article
41. Lendrem D, Mitchell S, McMeekin P, et al. Health-related utility values of patients with primary Sjögren’s syndrome and its predictors. Ann Rheum Dis 2014;73(7):1362-8.10.1136/annrheumdis-2012-20286323761688
Search in Google Scholar Back to article
42. D’Cruz DP, Khamashta MA, Hughes GR. Systemic lupus erythematosus. Lancet 2007;369(9561):587-96.10.1016/S0140-6736(07)60279-717307106
Search in Google Scholar Back to article
43. Menzies S, O’Shea F, Galvin S, Wynne B. Oral manifestations of lupus. Ir J Med Sci 2018;187(1):91-3.10.1007/s11845-017-1622-z28470356
Search in Google Scholar Back to article
44. Brennan MT, Valerin MA, Napenas JJ, Lockhart PB. Oral manifestations of patients with lupus erythematosus. Dent Clin N Am 2005;49(1):127-41.10.1016/j.cden.2004.07.00615567365
Search in Google Scholar Back to article
45. Fortuna G, Brennan MT. Systemic lupus erythematosus: epidemiology, pathophysiology, manifestations, and management. Dent Clin N Am 2013;57(4):631-55.10.1016/j.cden.2013.06.00324034070
Search in Google Scholar Back to article
46. Yazdany J. Health-related quality of life measurement in adult systemic lupus erythematosus: Lupus Quality of Life (LupusQoL), Systemic Lupus Erythematosus-Specific Quality of Life Questionnaire (SLEQOL), and Systemic Lupus Erythematosus Quality of Life Questionnaire (L-QoL). Arthritis Care Res 2011;63(0 11):413-9.10.1002/acr.20636343775422588761
Search in Google Scholar Back to article
47. Wang SL, Hsieh E, Zhu LA, Wu B, Lu LJ. Comparative Assessment of Different Health Utility Measures in Systemic Lupus Erythematosus. Sci Rep 2015;5:13297.10.1038/srep13297454399026293686
Search in Google Scholar Back to article
48. Denton CP, Khanna D. Systemic sclerosis. Lancet 2017;390(10103):1685-99.10.1016/S0140-6736(17)30933-928413064
Search in Google Scholar Back to article
49. Jung S, Martin T, Schmittbuhl M, Huck O. The spectrum of orofacial manifestations in systemic sclerosis: A challenging management. Oral Dis 2017;23(4):424-39.10.1111/odi.1250727196369
Search in Google Scholar Back to article
50. Puzio A, Przywara-Chowaniec B, Postek-Stefańska L, Mrówka-Kata K, Trzaska K. Systemic sclerosis and its oral health implications. Adv Clin Exp Med 2019;28(4):547-54.10.17219/acem/7684730079996
Search in Google Scholar Back to article
51. Onesti MG, Fioramonti P, Carella S, Fino P, Marchese C, Scuderi N. Improvement of Mouth Functional Disability in Systemic Sclerosis Patients over One Year in a Trial of Fat Transplantation versus Adipose-Derived Stromal Cells. Stem Cells Int 2016;2016:2416192.10.1155/2016/2416192473641926880939
Search in Google Scholar Back to article
52. Philipone E, Yoon AJ, Zegarelli D. Intraoral telangiectasias associated with Raynaud disease: A report of two cases. Quintessence Int 2010;41(1):17-20.10.4103/0975-8844.103488
Search in Google Scholar Back to article
53. Nascimento IS, Bonfa E, de Carvalho JF, et al. Clues for previously undiagnosed connective tissue disease in patients with trigeminal neuralgia. Clin Rheumatol 2010;15(5):205-8.10.1097/RHU.0b013e3181e928e620661065
Search in Google Scholar Back to article
54. Ferreira E, Christmann RB, Borba EF, Borges CT, Siqeira JT, Bonfa E. Mandibular function is severely impaired in systemic sclerosis patients. J Orofac Pain 2010;24(2):197-202.
Search in Google Scholar Back to article
55. Park EH, Strand V, Oh YJ, Song YW, Lee EB. Healthrelated quality of life in systemic sclerosis compared with other rheumatic diseases: a cross-sectional study. Arthritis Res Ther 2019;21(1):61.10.1186/s13075-019-1842-x637771430770765
Search in Google Scholar Back to article
56. Reay N. The quality of life in patients with diffuse and limited systemic sclerosis. PhD thesis, University of Leeds, 2008.
Search in Google Scholar Back to article
57. Raymakers AJ, Tsao NW, Marra CA, Clements PJ, Khanna D. Health State Utilities and Disease Duration in Systemic Sclerosis: Is There an Association? J Rheumatol 2016;43(10):1832-7.10.3899/jrheum.160162
Search in Google Scholar Back to article
58. Alrashdan MS, Cirillo N, McCullough M. Oral lichen planus: a literature review and update. Arch Dermatol Res 2016;308(8):539-51.10.1007/s00403-016-1667-227349424
Search in Google Scholar Back to article
59. González-Moles MÁ, Ruiz-Ávila I, González-Ruiz L, Ayén Á, Gil Montoya JA, Ramos-García P. Malignant transformation risk of oral lichen planus: A systematic review and comprehensive meta-analysis. Oral Oncol 2019;(96):121-30.10.1016/j.oraloncology.2019.07.01231422203
Search in Google Scholar Back to article
60. Mutafchieva MZ, Draganova-Filipova MN, Zagorchev PI, Tomov GT. Oral Lichen Planus - Known and Unknown: a Review. Folia Med 2018;60(4):528-35.10.2478/folmed-2018-001731188760
Search in Google Scholar Back to article
61. Dalirsani, Z., Delavarian, Z., Javadzade-Bolouri, A., et al. (2011). Psychiatric disorders - worldwide advances. Rijeka, Croatia: InTech.
Search in Google Scholar Back to article
62. Sugerman PB, Savage NW, Walsh LJ, et al. The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med 2002;13(4):350-65.10.1177/15441113020130040512191961
Search in Google Scholar Back to article
63. Bagan JV, Eisen D, Scully C. The diagnosis and management of oral lichen planus: a consensus approach. Oral Biosci Med 2004;1:21-7.
Search in Google Scholar Back to article
64. Chiang CP, Yu-Fong Chang J, Wang YP, Wu YH, Lu SY, Sun A. Oral lichen planus - Differential diagnoses, serum autoantibodies, hematinic deficiencies, and management. J Formos Med Assoc 2018;117(9):756-65.10.1016/j.jfma.2018.01.02129472048
Search in Google Scholar Back to article
65. González-Moles MÁ, Warnakulasuriya S, González- Ruiz I, et al. Worldwide prevalence of oral lichen planus: A systematic review and meta-analysis. Oral Dis 2020.10.1111/odi.1332332144836
Search in Google Scholar Back to article
66. Babu A, Chellaswamy S, Muthukumar S, Pandey B, Jayaraj M, Francis S. Bullous Lichen Planus: Case Report and Review. J Pharm Bioallied Sci 2019;11(2): S499–S506.10.4103/JPBS.JPBS_58_19655537531198396
Search in Google Scholar Back to article
67. Eisen D, Carrozzo M, Bagan Sebastian JV, Thongprasom K. Number V oral lichen planus: clinical features and management. Oral Dis 2005;11:338–49.10.1111/j.1601-0825.2005.01142.x16269024
Search in Google Scholar Back to article
68. Wiriyakijja P, Porter S, Fedele S, et al. Health-related quality of life and its associated predictors in patients with oral lichen planus: a cross-sectional study. Int Dent J 2020;71(2):140-52.10.1111/idj.12607927531632875594
Search in Google Scholar Back to article
69. Wiriyakijja P, Fedele S, Porter SR, Mercadante V, Ni Riordain R. Patient-reported outcome measures in oral lichen planus: A comprehensive review of the literature with focus on psychometric properties and interpretability. J Oral Pathol Med 2018;47(3):228-39.10.1111/jop.1260428622422
Search in Google Scholar Back to article
70. Wiriyakijja P, Porter S, Fedele S, et al. The patient acceptable symptom state in oral lichen planus: identification of cut-off threshold scores in measures of pain and quality of life. Clin Oral Invest 2020.10.1007/s00784-020-03695-633201359
Search in Google Scholar Back to article
71. Tavakolpour S, Mahmoudi H, Mirzazadeh A, et al. Pathogenic and protective roles of cytokines in pemphigus: A systematic review. Cytokine 2020;129:155026.10.1016/j.cyto.2020.15502632058276
Search in Google Scholar Back to article
72. Ghaedi F, Etesami I, Aryanian Z, et al. Drug-induced pemphigus: A systematic review of 170 patients. Int Immunopharmacol 2021;92:107299.10.1016/j.intimp.2020.10729933418246
Search in Google Scholar Back to article
73. Kasperkiewicz M, Ellebrecht CT, Takahashi H, et al. Pemphigus. Nat Rev Dis Primers 2017;(3):17026.10.1038/nrdp.2017.26590173228492232
Search in Google Scholar Back to article
74. Swinson B, Witherow H, Norris P, Lloyd T. Oral manifestations of systemic diseases. Hosp Med 2004;65(2):92-9.10.12968/hosp.2004.65.2.1206714997776
Search in Google Scholar Back to article
75. Davenport S, Chen SY, Miller AS. Pemphigus vulgaris: clinicopathologic review of 33 cases in the oral cavity. Int J Periodontics Restorative Dent 2001;21(1):85-90.
Search in Google Scholar Back to article
76. Sebaratnam DF, Hanna AM, Chee SN, et al. Development of a quality-of-life instrument for autoimmune bullous disease: The Autoimmune Bullous Disease Quality of Life questionnaire. JAMA Dermatol 2013;149(10):1186-91.10.1001/jamadermatol.2013.497223925444
Search in Google Scholar Back to article
77. Hajdu K, Brodszky V, Stalmeier PFM, et al. Patient-assigned health utility values for controlled and uncontrolled pemphigus vulgaris and foliaceus. J Eur Acad Dermatol Venereol 2019;33(11):2106-13.10.1111/jdv.1576531265151
Search in Google Scholar Back to article
78. Bagan J, Lo Muzio L, Scully C. Mucosal disease series. Number III. Mucous membrane pemphigoid. Oral Dis 2005;11(4):197-218.10.1111/j.1601-0825.2005.01140.x15984952
Search in Google Scholar Back to article
79. Bilgic A, Aydin F, Sumer P, et al. Oral health related quality of life and disease severity in autoimmune bullous diseases. Niger J Clin Pract 2020;23(2):159-64.10.4103/njcp.njcp_216_19
Search in Google Scholar Back to article
80. Saleh MA, Zaraa I, Doss N, Saleh NA, Murrell DF. Assessment of the quality of life of Egyptian and Tunisian autoimmune bullous diseases’ patients using an Arabic version of the autoimmune bullous disease quality of life and the treatment of autoimmune bullous disease quality of life questionnaires. An Bras Dermatol 2019;94(4):399-404.10.1590/abd1806-4841.20197198700703231644610
Search in Google Scholar Back to article
81. Vavricka SR, Schoepfer A, Scharl M, Lakatos PL, Navarini A, Rogler G. Extraintestinal Manifestations of Inflammatory Bowel Disease. Inflamm Bowel Dis 2015;21(8):1982-92.10.1097/MIB.0000000000000392451168526154136
Search in Google Scholar Back to article
82. Adam H, Alqassas M, Saadah OI, Mosli M. Extraintestinal Manifestations of Inflammatory Bowel Disease in Middle Eastern Patients. J Epidemiol Glob Health 2020;10(4):298-303.10.2991/jegh.k.200330.001775885032959603
Search in Google Scholar Back to article
83. Jajam M, Bozzolo P, Niklander S. Oral manifestations of gastrointestinal disorders. J Clin Exp Dent 2017;9(10):1242-8.10.4317/jced.54008569415529167716
Search in Google Scholar Back to article
84. Kumar KM, Nachiammai N, Madhushankari GS. Association of oral manifestations in ulcerative colitis: A pilot study. J Oral Maxillofac Pathol 2018;22(2):199-203.10.4103/jomfp.JOMFP_223_16609737330158772
Search in Google Scholar Back to article
85. Cao Q, Huang YH, Jiang M, Dai C. The prevalence and risk factors of psychological disorders, malnutrition and quality of life in IBD patients. Scand J Gastroenterol 2019;54(12):1458-66.10.1080/00365521.2019.169789731791216
Search in Google Scholar Back to article
86. Marinelli C, Savarino E, Inferrera M, et al. Factors Influencing Disability and Quality of Life during Treatment: A Cross-Sectional Study on IBD Patients. Gastroent Res Pract 2019;2019:5354320.10.1155/2019/5354320672145231531015
Search in Google Scholar Back to article
87. Malinowski KP, Kawalec P. Health utility of patients with Crohn’s disease and ulcerative colitis: a systematic review and meta-analysis. Expert Rev Pharm Out 2016;16(4):441-53.10.1080/14737167.2016.1190644
Search in Google Scholar Back to article
88. Telega G, Bennet TR, Werlin S. Emerging new clinical patterns in the presentation of celiac disease. Arch Pediatr Adolesc Med 2008;162(2):164-8.10.1001/archpediatrics.2007.3818250242
Search in Google Scholar Back to article
89. Guandalini S, Assiri A. Celiac disease: a review. JAMA Pediatr 2014;168(3):272-8.10.1001/jamapediatrics.2013.385824395055
Search in Google Scholar Back to article
90. Deepak C, Berry N, Vaiphei K, Dhaka N, Sinha SK, Kochhar R. Quality of life in celiac disease and the effect of gluten-free diet. JGH Open 2018;2(4):124-8.10.1002/jgh3.12056620704630483576
Search in Google Scholar Back to article
91. Casellas F, Rodrigo L, Molina-Infante J, et al. Transcultural adaptation and validation of the Celiac Disease Quality of Life (CD-QOL) Survey, a specific questionnaire to measure quality of life in patients with celiac disease. Rev Esp Enferm Dig 2013;105(10):585-93.10.4321/S1130-01082013001000003
Search in Google Scholar Back to article
92. Long RG, Hlousek L, Doyle JL. Oral manifestations of systemic diseases. Mt Sinai J Med 1998;65(5-6):309-15.
Search in Google Scholar Back to article
93. Grando LJ, Mello AL, Salvato L, Brancher AP, Del Moral JA, Steffenello-Durigon G. Impact of leukemia and lymphoma chemotherapy on oral cavity and quality of life. Spec Care Dentist 2015;35(5):236-42.10.1111/scd.1211325963973
Search in Google Scholar Back to article
94. Harreiter J, Roden M. Diabetes mellitus – Definition, Klassifikation, Diagnose, Screening und Prävention (Update 2019). Wien Klin Wochenschr 2019;131(1):6-15.10.1007/s00508-019-1450-430980151
Search in Google Scholar Back to article
95. Stanisic D, Obradovic R, Vujovic S, Jovanovic M, Zivkovic V. The Connection of Periodontal Disease and Diabetes Mellitus: The Role of Matrix Metalloproteinases and Oxidative Stress. Ser J Exp Clin Res 2019.10.2478/sjecr-2019-0051
Search in Google Scholar Back to article
96. Leite RS, Marlow NM, Fernandes JK, Hermayer K. Oral health and type 2 diabetes. Am J Med Sci 2013;345(4):271-3.10.1097/MAJ.0b013e31828bdedf362328923531957
Search in Google Scholar Back to article
97. Kesić L, Petrović D, Obradović R, Gasić J, Todorović K. Diabetes mellitus and periodontal disease. Med Pregl 2009;62(11-12):534-8.10.2298/MPNS0912534K
Search in Google Scholar Back to article
98. Eke PI, Dye BA, Wei L, Thornton-Evans GO, Genco RJ, CDC Periodontal Disease Surveillance workgroup. Prevalence of periodontitis in adults in the United States: 2009 and 2010. J Dent Res 2012;91(10):914-20.10.1177/002203451245737322935673
Search in Google Scholar Back to article
99. Obradović R, Kesić L, Mihailović D, Jovanović G, Antić S, Brkić Z. Low-level lasers as an adjunct in periodontal therapy in patients with diabetes mellitus. Diabetes Technol Ther 2012;14(9):799-803.10.1089/dia.2012.0027342933022928615
Search in Google Scholar Back to article
100. Palamenghi L, Carlucci MM, Graffigna G. Measuring the Quality of Life in Diabetic Patients: A Scoping Review. J Diabetes Res 2020;2020:5419298.10.1155/2020/5419298726134232566680
Search in Google Scholar Back to article
101. Cervino G, Terranova A, Briguglio F, et al. Diabetes: Oral Health Related Quality of Life and Oral Alterations. Biomed Res Int 2019;2019:5907195.10.1155/2019/5907195644230731011577
Search in Google Scholar Back to article
102. Zhang P, Brown MB, Bilik D, Ackermann RT, Li R, Herman WH. Health utility scores for people with type 2 diabetes in U.S. managed care health plans: results from Translating Research Into Action for Diabetes (TRIAD). Diabetes Care 2012;35(11):2250-6.10.2337/dc11-2478347690622837369
Search in Google Scholar Back to article
103. Hayes A, Arima H, Woodward M, et al. Changes in Quality of Life Associated with Complications of Diabetes: Results from the ADVANCE Study. Value Health 2016;19(1):36-41.10.1016/j.jval.2015.10.01026797234
Search in Google Scholar Back to article
104. Khalaf MW, Khader R, Cobetto G, Yepes JF, Karounos DG, Miller CS. Risk of adrenal crisis in dental patients: results of a systematic search of the literature. J Am Dent Assoc 2013;144(2):152-60.10.14219/jada.archive.2013.009423372131
Search in Google Scholar Back to article
105. Tucci V, Sokari T. The clinical manifestations, diagnosis, and treatment of adrenal emergencies. Emerg Med Clin N Am 2014;32(2):465-84.10.1016/j.emc.2014.01.00624766944
Search in Google Scholar Back to article
106. Pala A, Chowbey R, Sonvanshi N, Patel D, Shah A, Venkatesh A. A review on oral manifestations of systemic diseases. Int J Oral Health Med Res 2016;2(6):131-2.
Search in Google Scholar Back to article
107. Meyer G, Koch M, Herrmann E, Bojunga J, Badenhoop K. Longitudinal AddiQoL scores may identify higher risk for adrenal crises in Addison’s disease. Endocrine 2018;60(2):355-61.10.1007/s12020-017-1513-029388043
Search in Google Scholar Back to article
108. Łabuz-Roszak B, Niewiadomska E, Starostka-Tatar A, et al. Multiple sclerosis: oral health, behaviours and limitations of daily oral hygiene - a questionnaire study. Neurol Neurochir Pol 2019;53(4):271-6.10.5603/PJNNS.a2019.003331441495
Search in Google Scholar Back to article
109. Walton C, King R, Rechtman L, et al Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Mult Scler 2020;26(14):1816-21.10.1177/1352458520970841772035533174475
Search in Google Scholar Back to article
110. Manchery N, Henry JD, Nangle MR. A systematic review of oral health in people with multiple sclerosis. Community Dent Oral Epidemiol 2020;48(2):89-100.10.1111/cdoe.1251231815299
Search in Google Scholar Back to article
111. Carvalho LSC, Nascimento OJM, Rodrigues LLFR, et al. Relationship between Expanded Disability Status Scale scores and the presence of temporomandibular disorders in patients with multiple sclerosis. Eur J Dent 2018;12:144-8.10.4103/ejd.ejd_91_17588346729657540
Search in Google Scholar Back to article
112. Sexton C, Lalloo R, Stormon N, et al. Oral health and behaviours of people living with Multiple Sclerosis in Australia. Community Dent Oral Epidemiol 2019;47(3):201-9.10.1111/cdoe.1244530618108
Search in Google Scholar Back to article
113. Jongen PJ. Health-Related Quality of Life in Patients with Multiple Sclerosis: Impact of Disease-Modifying Drugs. CNS Drugs 2017;31(7):585-602.10.1007/s40263-017-0444-x551129828608280
Search in Google Scholar Back to article
114. Højsgaard Chow H, Schreiber K, Magyari M, et al. Progressive multiple sclerosis, cognitive function, and quality of life. Brain Behav 2018;8(2):e00875.10.1002/brb3.875582257529484253
Search in Google Scholar Back to article
115. Hamza SA, Asif S, Bokhari SAH. Oral health of individuals with dementia and Alzheimer’s disease: A review. J Indian Soc Periodontol 2021;25(2):96-101.10.4103/jisp.jisp_287_20804107133888939
Search in Google Scholar Back to article
116. Ming Y, Hsu SW, Yen YY, Lan SJ. Association of oral health-related quality of life and Alzheimer disease: A systematic review. J Prosthet Dent 2020;124(2):168-75.10.1016/j.prosdent.2019.08.01531753458
Search in Google Scholar Back to article
117. Plessas A, Paisi M. Is there an association between oral health-related quality of life and Alzheimer’s disease? Evid Based Dent 2020;21:124–5.10.1038/s41432-020-0132-4
Search in Google Scholar Back to article
118. Perales J, Cosco TD, Stephan BC, Haro JM, Brayne C. Health-related quality-of-life instruments for Alzheimer’s disease and mixed dementia. Int Psychogeriatr 2013;25(5):691-706.10.1017/S104161021200229323347698
Search in Google Scholar Back to article
119. van de Beek M, van Steenoven I, Ramakers IHGB, et al. Trajectories and Determinants of Quality of Life in Dementia with Lewy Bodies and Alzheimer’s Disease. J Alzheimers Dis 2019;70(2):389-97.10.3233/JAD-190041683949731177218
Search in Google Scholar Back to article
120. Balash Y, Korczyn AD, Migirov AA, Gurevich T. Quality of life in Parkinson’s disease: A gender-specific perspective. Acta Neurol Scand 2019;140(1):17-22.10.1111/ane.1309530953570
Search in Google Scholar Back to article
121. Barbe AG, Bock N, Derman SH, Felsch M, Timmermann L, Noack MJ. Self-assessment of oral health, dental health care and oral health-related quality of life among Parkinson’s disease patients. Gerodontology 2017;34(1):135-143.10.1111/ger.1223727231151
Search in Google Scholar Back to article
122. Francisconi CF, Caldas RJ, Oliveira Martins LJ, Fischer Rubira CM, da Silva Santos PS. Leukemic oral manifestations and their management. Asian Pac J Cancer Prev 2016;17(3):911-5.10.7314/APJCP.2016.17.3.911
Search in Google Scholar Back to article
123. Cella D, Jensen SE, Webster K, et al. Measuring healthrelated quality of life in leukemia: the Functional Assessment of Cancer Therapy-Leukemia (FACT-Leu) questionnaire. Value Health 2012;15(8):1051-8.10.1016/j.jval.2012.08.221023244807
Search in Google Scholar Back to article
124. Zeng X, Sui M, Liu R, et al. Assessment of the health utility of patients with leukemia in China. Health Qual Life Outcomes 2021;19(1):65.10.1186/s12955-021-01711-1791342833639980
Search in Google Scholar Back to article
125. Almeida TM, Cavalcanti ÉF, Freitas AD, Magalhães RJ, Maiolino A, Torres SR. Can dentists detect multiple myeloma through oral manifestations? Hematol Transfus Cell Ther 2018;40(1):43-9.10.1016/j.bjhh.2017.08.006
Search in Google Scholar Back to article
126. Delforge M, Minuk L, Eisenmann J, et al. Health-related quality-of-life in patients with newly diagnosed multiple myeloma in the FIRST trial: lenalidomide plus low-dose dexamethasone versus melphalan, prednisone, thalidomide. Haematologica 2015;100(6):826-33.10.3324/haematol.2014.120121445062925769541
Search in Google Scholar Back to article
127. Stead ML, Brown JM, Velikova G, et al. Development of an EORTC questionnaire module to be used in healthrelated quality-of-life assessment for patients with multiple myeloma. European Organization for Research and Treatment of Cancer Study Group on Quality of Life. Br J Haematol 1999;104(3):605-11.10.1046/j.1365-2141.1999.01206.x10086801
Search in Google Scholar Back to article
128. Proskorovsky I, Lewis P, Williams CD, et al. Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma. Health Qual Life Outcomes 2014;12(1):35.10.1186/1477-7525-12-35400782724618388
Search in Google Scholar Back to article
129. Golicki D, Jaśkowiak K, Wójcik A, et al. EQ-5DDerived Health State Utility Values in Hematologic Malignancies: A Catalog of 796 Utilities Based on a Systematic Review. Value Health 2020;23(7):953-68.10.1016/j.jval.2020.04.182532762998
Search in Google Scholar Back to article
130. Montero PH, Patel SG. Cancer of the oral cavity. Surg Oncol Clin 2015;24(3):491-508.10.1016/j.soc.2015.03.006501820925979396
Search in Google Scholar Back to article
131. Abbas S, Tariq MUU, Raheem A, et al. Assessment of Factors Affecting Quality of Life in Oral Squamous Cell Carcinoma Patients Using University of Washington Quality of Life Questionnaire. Cureus 2019;11(1):e3904.10.7759/cureus.3904642454730911459
Search in Google Scholar Back to article
132. Yu WY, Waalboer-Spuij R, Bremer R, et al. Validation of the English Basal and Squamous Cell Carcinoma Quality of Life (BaSQoL) Questionnaire. Dermatol Surg 2020;46(3):327-34.10.1097/DSS.000000000000204631397784
Search in Google Scholar Back to article
133. Mod D, Mod H, Jha A. Oral and dental complications of head and neck radiotherapy and their management. J Nepal Health Res Counc 2013;11(25):300-4.
Search in Google Scholar Back to article
134. Schwarzinger M, Luchini S, EPICORL Study Group. Estimating health state utility from activities of daily living in the French National Hospital Discharge Database: a feasibility study with head and neck cancer. Health Qual Life Outcomes 2019;17(1):129.10.1186/s12955-019-1195-9665925131345227
Search in Google Scholar Back to article
135. Doward LC, McKenna SP, Whalley D. The development of the L-QoL: a quality-of-life instrument specific to systemic lupus erythematosus. Ann Rheum Dis 2009;68(2):196-200.10.1136/ard.2007.08600918385276
Search in Google Scholar Back to article
136. Sansare, K, Kapoor R, Karjodkar F. Validity of Chronic Oral Mucosal Diseases Questionnaire in oral submucous fibrosis. Clin Oral Invest 2019;23:873–7.10.1007/s00784-018-2504-029948274
Search in Google Scholar Back to article
137. Guyatt G, Mitchell A, Irvine EJ, et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology 1989;96(3):804-10.10.1016/0016-5085(89)90905-0
Search in Google Scholar Back to article
138. Wilburn J, McKenna SP, Twiss J, Kemp K, Campbell S. Assessing quality of life in Crohn’s disease: development and validation of the Crohn’s Life Impact Questionnaire (CLIQ). Qual Life Res 2015;24(9):2279-88.10.1007/s11136-015-0947-125702267
Search in Google Scholar Back to article
139. Dorn SD, Hernandez L, Minaya MT, et al. The development and validation of a new coeliac disease quality of life survey (CD-QOL). Aliment PharmTher 2010;31(6):666-75.10.1111/j.1365-2036.2009.04220.x20015103
Search in Google Scholar Back to article
140. Speight J, Woodcock AJ, Reaney MD, et al. The ‘QoLQ Diabetes’ – a novel instrument to assess quality of life for adults with type 1 diabetes undergoing complex interventions including transplantation. Diabet Med 2010;27(1):3-4.10.1111/j.1464-5491.2010.03029.x
Search in Google Scholar Back to article
141. Løvås K, Curran S, Oksnes M, Husebye ES, Huppert FA, Chatterjee VK. Development of a disease-specific quality of life questionnaire in Addison’s disease. J Clin Endocrinol Metab 2010;95(2):545-51.10.1210/jc.2009-171120016050
Search in Google Scholar Back to article

Systemic Diseases with Oral Manifestations and Their Impact on Health-Related Quality of Life

References

Paradigm

My account